Eldred Kary
Galectin Therapeutics Inc. · Director
Eldred Kary is listed in filings as Director at Galectin Therapeutics Inc.. This profile follows SEC Form 4 activity through Feb 9, 2026, including purchase activity. Recent filings connect the profile to Galectin Therapeutics Inc. (GALT). The current snapshot covers public activity from Jul 23, 2024 to Feb 9, 2026. Reported amounts are shown as $810 to $2.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $2.6k700 shares | BuyDec 23, 2025 | $3.73 | $4.18 | |
| $2.9k1k shares | BuyJul 21, 2025 | $2.93 | $4.18 | |
| $11k13.5k shares | BuyDec 24, 2024 | $0.82 | $4.18 | |
| $1.3k500 shares | BuyOct 23, 2024 | $2.60 | $4.18 | |
| $956400 shares | BuyJul 22, 2024 | $2.39 | $4.18 |